Consultant

Dr Nikos Diamantis

Consultant Medical Oncologist, Gastrointestinal cancers and NET, Clinical Lead for Colorectal Cancer
MD, MRCP(UK), PhD
Profile Photo for Nikos Diamantis

Dr Nikos Diamantis is a Medical Oncology Consultant at Royal Free Trust specialising in Gastrointestinal cancers including colorectal, oesphageal, gastric, pancreatic, liver and bile duct cancers, and Neuroendocrine tumours. Dr Diamantis is a Principal Investigator for a number of phase 2/3 studies and is regularly publishing his research activity in peer reviewed journals.

Oncology
English, Greek
In-person, Phone call, Video call

Related conditions

1 / 5

Colorectal cancer

Our world-class oncologists and colorectal surgeons are highly experienced at diagnosing and treating colorectal cancer. Speak to our team to find out more

2 treatments available

Neuroendocrine cancer

Neuroendocrine tumours (NETs) are abnormal masses of neuroendocrine cells. They can be benign or malignant and most commonly occur in the digestive system.

1 treatment available

Rare cancers

We have a number of world-leading specialists who are highly experienced in diagnosing and treating rare cancers. Speak to our expert team to find out more

Pancreatic cancer

Cancer of the pancreas is a malignant tumour that forms in part of the pancreas.

Barrett's oesophagus

Our world-class gastroenterologists are highly experienced at diagnosing and treating Barrett's oesophagus.

1 treatment available

Bio

Dr Nikos Diamantis is a Medical Oncology Consultant at Royal Free Trust specialising in colorectal, oesphageal, gastric, pancreatic, liver and bile duct cancers, and Neuroendocrine tumours. He is the Clinical Lead for colorectal cancer.

Dr Diamantis underwent specialist training at the Imperial College Healthcare Hammersmith, St Mary's and Harefield Hospitals. He was awarded the Greek national Oncology fellowship scholarship and went on to conduct clinical research for 2 years at the Drug Development Unit of the Royal Marsden.

Research interests include immunotherapy for GI malignancies and first in human clinical trials. Dr Diamantis is a Principal Investigator for a number of Phase 2 and 3 trials.

More information

  • Consultant Medical Oncologist Gastrointestinal Cancers, NET. Clinical Lead for Colorectal cancer
    The Royal Free NHS Foundation Trust
  • Bile duct cancers
  • Neuroendocrine tumours
  • Liver
  • Year qualified 2004
  • National and Kapodistrian University of Athens, Greece

Nivolumab Combination Therapy in Advanced Esophageal Squamous-Cell Carcinoma

Year: 2022
Publisher: New England Journal of Medicine

Prevalence and impact of COVID-19 sequelae on treatment and survival of patients with cancer who recovered from SARS-CoV-2 infection: evidence from the OnCovid retrospective, multicentre registry study

Year: 2021
Publisher: Lancet Oncol

Phase 1/2a trial of intravenous BAL101553, a novel controller of the spindle assembly checkpoint, in advanced solid tumours

Year: 2018
Published: Br Journal of Cancer

  • Nominated for the Macmillan Professional excellence award for the development 2019 of the Barts Health Acute Oncology service
  • ECCO-AACR-EORTC-ESMO Fellowship (Flims) 2016 Methods in Clinical Cancer Research Workshop
  • ASCO Merit Award 2016 Co-author, American Society of Clinical Oncology
  • HESMO Scholarship, Postgraduate Fellowship 2014
  • Awarded by the Hellenic Society of Medical Oncology
  • PhD with Honors 2010 National and Kapodistrian University of Athens, Greece

Contact us

Request an appointment with our world-leading consultants today, or speak to our helpful advisors for tailored advice.

Get in touch